Ooni Koda
  1. Home
  2. /
  3. Newsfeed
  4. /
  5. Biofarm records a net profit of 77 million...

Biofarm records a net profit of 77 million lei in 2023, up 9% compared to 2022

March 4, 2024

Biofarm, (stock symbol BIO), one of the most important drug manufacturers in Romania, ended 2023 with a net profit of about 77 million lei, up 9% from the previous year and a turnover of approx. 280 million lei, according to preliminary results (unaudited).

 

"In 2023, we successfully implemented cost optimization strategies, focusing in particular on two of our company values: performance and end-consumer care. In doing so, we were able to identify effective ways to control our expenses, even in the context of rising raw material and packaging prices. The Consumer Healthcare category in Romania is becoming more and more competitive year by year, marked also by a slight decline in volumes in 2023 compared to 2022. However, we ended 2023 managing to consolidate our position on the market, with a positive evolution of the volume market share and to contribute positively on the quality of life of patients and consumers in Romania", said Cătălin Vicol, Biofarm CEO.

 

Biofarm continued to strengthen its market share in the Consumer Healthcare (CHC) segment, and ended 2023 in second position in terms of number of units sold.

 

The company dominates in value in 6 key categories across brands: Bixtonim, Triferment, Colebil, Extravalerianic, Carmol and Carbocit. In addition, Biofarm is the volume leader in no less than 8 categories, highlighting the outstanding performance of the brands Bixtonim, Colebil, Triferment, Sennalax, Extravalerianic, Carmol, Carbocit and Nervocalmin. These results confirm the success of Biofarm's approach and commitment to innovation. Through its achievements, the company continues to establish itself as a trusted player in Consumer Healthcare, offering effective and affordable solutions to consumers.

 

Biofarm has two drug factories in Bucharest and a product testing and development unit, and its portfolio of over 100 products covers the most important therapeutic areas of the Consumer Healthcare division (digestive & metabolic, respiratory & ORL, cardiovascular & circulatory, nervous system). Constant innovation in the development of new products is one of the fundamental elements for Biofarm's expansion and strengthening its position among the leaders in the pharmaceutical industry.

The information provided by KomuniK

The text of this article has been partially taken from the publication:
https://komunik.ro/biofarm-records-a-net-profit-of-77-million-lei-in-2023-up-9-compared-to-2022/
Read in full - click here
Romanian police brings man on Most Wanted list back to serve jail sentence

On Monday, December 23, Romanian police brought Nica Robert Florin back to the country. The man convicted of possession of high-risk drugs, bodily harm, and driving under the influence of alcohol, is listed among Romania’s Most Wanted category and was also wanted internationally. Romanian authorities revealed at the beginning of October that they had indications […]

Călin Georgescu’s campaign for Romanian presidency supported by pandemic-era Russian disinformation network, Financial Times says

An investigation by the famous British newspaper Financial Times revealed that the campaign of former Romanian presidential candidate Călin Georgescu was supported by a Russian network also used during the pandemic in France and Germany to instill fear of vaccines. The newspaper’s investigation began in continuation of those by Bulgarian and Romanian journalists at BG...

Live concerts and multimedia shows at New Year’s Eve event in Bucharest’s Titan Park

Bucharest’s District 3 City Hall will once again organize a special New Year’s Eve event in Titan Park, with a program of live concerts, multimedia shows, and even a simulation of the Northern Lights. The event, set to begin at 8:00 PM on December 31, will focus on the theme of infinity. “If you missed […]

Romania opens new segment of much-awaited Moldova highway

Traffic on Lot 1 of the A7 Ploiești-Buzău highway, stretching 21 kilometers in southern Romania, was officially opened on Monday, December 23. With this opening, 102 kilometers of the total 320 kilometers of the highway are now usable.  The Moldova Highway, as it has been called, is meant to connect Romania's economically underdeveloped eastern regions to […]

Majority shareholder of Romanian online marketplace eMAG acquires Latin-American travel agency

The Dutch technology investor Prosus NV, also the majority shareholder of Romania’s largest online retailer eMAG, is set to buy the online travel agency Despegar.com Corp, focused on Latin America, for approximately USD 1.7 billion. The purchase consideration will be funded from existing cash resources, the company said. Founded in Argentina in 1999, Despegar is one […]

Romania’s new Forestry Code safeguards forests around Bucharest, paves way for creating green belts nationwide

The new Forestry Code, which passed the Parliament vote on December 17 and was signed into law by president Klaus Iohannis on December 20, includes provisions that protect all forests in Ilfov, the county surrounding Bucharest, making them the cornerstone of the future green belt around the capital city. Moreover, it legislates green belts nationwide, […]